Clinical Trial Update: Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial tested whether spironolactone prevents progression of coronary artery calcification and vascular calcification in peritoneal dialysis patients; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Calcification
• Vascular Calcification

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Professor Fernando Figueira Integral Medicine Institute | Conditions: Coronary Artery Calcification, Vascular Calcification | Phase 3 | Status: COMPLETED